Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus
Article in Pharmaceutics (October 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review
Article in Diabetes Therapy (October 2023)
A review of the evidence on cardiovascular outcomes from obesity treatment
Article in Obesity Pillars (May 2023)